Investor mix
6 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 2 | 33% |
Antibody discovery and optimization platform for drug development
6 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 2 | 33% |